Bacterial pneumonia and pandemic influenza could there be an Impact on a sewage treatment plant? Andrew Singer Centre for Ecology.

Slides:



Advertisements
Similar presentations
Antimicrobial Prescribing in the Management of COPD
Advertisements

Treatment of infectious diseases. Drugs used in the treatment of bacterial diseases can be grouped into categories based on their modes of action: 1.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Adriana Weinberg, MD University of Colorado Denver.
How influenza pandemic control can lead to unpreparedness: modelling the ecotoxicity of pharmaceutical usage Andrew Singer Centre for Ecology.
Public Health Interventions: lessons learned Mark Loeb MD, MSc McMaster University.
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
Neil Ferguson Dept. of Infectious Disease Epidemiology Faculty of Medicine Imperial College Antiviral use in a pandemic: predicting impact and the risk.
Communicable Disease Surveillance & Response WHO-WPRO Pandemic (H1N1) 2009 situation and response in the Western Pacific Region Takeshi Kasai Communicable.
Ecotoxicity Risks During an Influenza Pandemic Andrew Singer Centre for Ecology & Hydrology Wallingford, UK.
BioCote® Antimicrobial Silver Ion Technology Providing proven antimicrobial protection.
Pneumonia Sapna Bamrah, MD CDC
Challenges of the 2009 H1N1 Pandemic Influenza: Charles Penn Global Influenza Programme World Health Organization Geneva.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
How influenza pandemic control can lead to unpreparedness: modelling the ecotoxicity of pharmaceutical usage Andrew Singer Centre for Ecology.
Miriam Nuño Harvard School of Public Health, USA Gerardo Chowell Los Alamos National Laboratory, USA Abba Gumel University of Manitoba, Canada AIMS/DIMACS/SACEMA.
The role of cross-immunity and vaccines on the survival of less fit flu-strains Miriam Nuño Harvard School of Public Health Gerardo Chowell Los Alamos.
Should we change the recommendations related to antibiotic drug dosage/drug duration? Workshop on Economic Epidemiology Makerere University August, 2009.
Influenza Treatment Project Groups 7 and 8 Among patients hospitalized with influenza, does intravenous immunoglobulin (FLU IVIG) + standard of care (SOC)
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
20 Answers About Influenza
How serious is the threat of an Avian flu Human Pandemic Avian (Bird) December 2005.
From Pandemic Preparedness to Management: UK experience Professor Lindsey Davies CBE FRCP FFPH National Director of Pandemic Influenza Preparedness.
Progress Report Global Pandemic Preparedness Beijing Conference January 2006 Dr Margaret Chan Assistant Director-General Communicable Diseases Representative.
ATP NVAC PIWG Report Pandemic Influenza Antiviral Strategies and Priority Groups Andrew T. Pavia M.D. University of Utah.
Emerging Diseases – Ready and Waiting Aileen J Plant Curtin University of Technology 19 October, 2004 Emerging Diseases: the human health perspective.
The University of Nottingham Practical issues related to pandemic deployment of antivirals Jonathan Van-Tam, MBE, DM, FFPH, FRIPH, Professor of Health.
Pandemic Influenza. Guidance for Pandemic Influenza: Infection Control in Hospitals and Primary Care Settings UK Pandemic Influenza Contingency Plan Operational.
What is Pandemic Influenza?. Pandemic Influenza A global outbreak of disease that occurs when a new influenza virus appears or “emerges” in the human.
Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.
Stanislaus County It’s Not Flu as Usual It’s Not Flu as Usual Pandemic Influenza Preparedness Renee Cartier Emergency Preparedness Manager Health Services.
National and International Spread of Antimicrobial Resistance: Clones and Genes Professor Alan Johnson, Health Protection Services - HPA.
Best Practice Guideline for the Workplace During Pandemic Influenza Occupational Health and Safety Employment Standards.
Learning Goals Appreciate that events on the other side of the world affect us.
120 januari 2011 Tamiflu in the environment Caroline Moermond Charles Bodar Lonneke van Leeuwen Mark Montforts Bianca van de Ven Suzanne Wuijts Monique.
Review and Discussion Time line courtesy of:
HHS Pandemic Influenza Preparedness Planning Julie Louise Gerberding, MD, MPH.
Respiratory Tract infections. PROF. AzzA ELMedany Department of pharmacology.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Food and Drug Administration
Incidence of hospitalisations in both groups Incidence of documented infections Abstract Problem statement: Patients on cancer chemotherapy are at substantial.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
Pandemic Influenza: What Is It and Why Should We Care? Dr. Judith A. Monroe, MD State Health Commissioner.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Global Pandemic Preparedness Research Efforts text Klaus Stöhr WHO Global Influenza Programme 3 Today  Medium-term applied research linked to medical.
Influenza like Illness Outbreak in a School Scenario.
Epidemiology and Surveillance: Lessons from Past Pandemics Arnold S. Monto, MD Professor of Epidemiology University of Michigan School of Public Health.
ANTIVIRAL AGENTS FOR THE PREVENTION AND TREATMENT ON INFLUENZA.
1 |1 | Situation Update Influenza A (H1N1), 26 May 09.
Participants Q.1: Which of these categories describes your work best? 1.Work on sustainable development regarding pharmaceuticals mainly at national level.
Antibiotics in the WWTP environment Heike Schmitt, Andrew C. Singer.
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
The Vermont Department of Health Update on Pandemic Threat Cort Lohff, MD, MPH State Epidemiologist Guidance Support Prevention Protection.
Bacteria: Beneficial, Infectious and Antibiotics
BACTERIA AND VIRUSES ANTIBIOTICS AND BACTERIAL RESISTANCE TO 1.
Antibiotics In Respiratory Infection To Use or Not to Use - that is the question. Dr. James Paton University of Glasgow.
The characteristics of the minimum inhibitory concentration of antibiotics on pulmonary infections in patients with cystic fibrosis S. Sciuca 1,2, L. Balanetchi.
Evaluation of Microbiological Risks Associated with Direct Potable Reuse (DPR) Water Microbiology Conference 2016 University of North Carolina May 2016.
Christopher P. Cannon, M. D. , Eugene Braunwald, M. D. , Carolyn H
Microbial Connections: the rise of antibiotic resistance
Microbial Connections: the rise of antibiotic resistance
Influenza pandemic: FluWorkLoss: Software to estimate work days lost
Environmental Effects on Human Health
Chapter 20: The Environment and Human Health
The Role of NICs in Influenza Surveillance
These slides are excerpted from a presentation titled “I Don’t Need A Flu Shot!” By Bill Rogers, Ball State University.
Craig Conlon MD, PhD, Employee Health Services Northern California
Microbial Connections: the rise of antibiotic resistance
Presentation transcript:

Bacterial pneumonia and pandemic influenza could there be an Impact on a sewage treatment plant? Andrew Singer Centre for Ecology & Hydrology

A gentle introduction to influenza pandemics!

What is an influenza pandemic? Pandemic Influenza = global spread of influenza infection in humans. Pandemic influenza is a rare but inevitable event: –1918 “Spanish influenza” (H1N1) –1957 “Asian influenza” (H2N2) –1968 “Hong Kong influenza” (H3N3)

Cases/Deaths Since 2003: 408/254 (62%) Why are we interested in this now?

One aim of the pandemic preparedness plan is to slow the spread of influenza, through: 1) vaccine development, stockpiling and distribution, 2) non-pharmaceutical measures, and 3) antiviral stockpiling and distribution 22 November 2007

Influenza Virus Influenza Cases Antiviral Use Secondary Infection Cases Antibiotic Use Treat with antibiotics 2 Treat with antivirals 1 Clinical cases of influenza 4 Secondary infections 3 3 Antiviral prophylaxis (outbreak and post exposure) Schematic of a Pharmaceutical Preparedness Plan

UK Guidelines This document is intended for use in the UK in the event that the World Health Organization declares that an influenza pandemic has started

What do we need to know to predict the arrival of antibiotics at a sewage treatment plant during a pandemic? Part I The scale of influenza infection (R0) The scale of prophylactic antiviral use (AVP) The scale of antiviral use to combat actual infections (AVT) The likelihood of secondary infections

Viral Infectivity (R 0 ) Influenza Cases Antiviral Treatment (AVT) Secondary Infection Cases Antibiotic Use R 0 = number of secondary cases of influenza produced by 1 infected individual R0R AVP 5% 10% 0% 30% 50% 70% AVT 2% 40% Antibiotic Developing a Model for Pharmaceutical Use During an Pandemic Influenza 54% reduction in pneumonia with antiviral treatment Kaiser (2003) Arch Intern Med; Nicholson (2000) Lancet; Treanor (2000) JAMA; Whitley (2000) Pediatr Infect Dis J Robust Pandemic Epidemiology Model AVP

What do we need to know to predict the arrival of antibiotics at a sewage treatment plant during a pandemic? Part II What antibiotics would be used during a pandemic (how does this compare to baseline)? How much of these would be excreted? How much of these might be lost in the sewer/sewage treatment plant? How this predicted concentration (PEC) compares to thresholds of microbial toxicity (NOEC)

Amoxicillin Doxycycline Moxifloxacin Clarithromycin Levofloxacin Erythromycin Cefotaxime Clavulanic acid Cefuroxime β-lactam Cephalosporin Macrolide Tetracycline Quinolone

How much will be given to a patient? Lim (2007) Thorax Antivirals Moderately sick Severely sick

Baseline Antibiotic Use (excreted in England) NHS BSA (2008) Those highlighted in red to be used in a pandemic

So as an example, today we might use 3.7 mg amoxicillin/d/capita (baseline), but in a pandemic this would rise an additional 1.3 to 74 mg/d/capita (an increase of 35 to 2000%)!

Probable Excretion to Sewage Works

Probable Loss in Sewage Works Estimates generated from STPWIN TM and an average % removal from the literature

Where might the antibiotic concentrations start to hurt bacteria?

Threshold Toxicity for Pandemic Antibiotics against Model Clinical Microorganisms Andrews JM (2001) J Antimicrob Chemother Reynolds et al. (1987) Chemosphere Note: we see impacts between 0.1 and 2 ug/L concentrations

R0R AVP 1% 5% 10% 0% 30% 50% 70% AVT 2% 40% 2° Infection A Realistic Scenario Will antibiotic concentrations in sewage get to harmful levels under a realistic scenario?

Antibiotic risk assessment from modelled scenario PEC = Predicted environmental concentration (in Sewage) NOEC = Predicted no observable effect concentration PEC NOEC 2° Infection > 1 Danger Level?

Under a realistic pandemic influenza scenario most of the individual predicted antibiotic concentrations exceed the NOEC for laboratory bacteria But what would it do to sewage bacteria?

Conclusions Pandemic usage of total antibiotics will greatly exceed ( %) that of baseline use It is important to note that increased antiviral prophylaxis might lower antibiotic use. Individual antibiotics in sewage are predicted to exceed concentrations required to inhibit laboratory test microorganisms.

Key Scientific Questions Might high antibiotic concentrations harm the complex microbial consortium in a sewage works (rather than just laboratory bugs)? How important are additive effects of combined antibiotic usage (similar modes of action)? Are antibiotics in unlimited supply?

Further Concerns Risk to sewage works failure & ‘downstream’ implications. Risk to drinking water under current models and after sewage treatment plant “failure.” Increasing antibiotic resistance problem.

Epidemiology Model Team V. Colizza, Complex Networks and Systems Group, ISI Foundation, Turin, Italy D. Balcan, A. Vespignani, School of Informatics, Indiana University, Bloomington, IN, USA River Flow Model Team V.D.J. Keller, R.J. Williams, Centre for Ecology & Hydrology, Wallingford, U.K Thankyou to…..

R0R AVP 5% 10% 0% 30% 50% 70% AVT 2% 40% 2° Infection Role of AVP on Controlling Antibiotics in the Thames (Realistic Worst Case Scenario)

Toxicity in Stretches of River (0% AVP) Where, Ro=2.7; AVP 0%, AVT 50%, p40%

Where, Ro=2.7; AVP 10%, AVT 50%, p40% Toxicity in Stretches of River (10% AVP)